Melatonin suppresses lung cancer metastasis by inhibition of epithelial-mesenchymal transition through targeting to Twist. [electronic resource]
- Clinical science (London, England : 1979) 03 2019
- 709-722 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1470-8736
10.1042/CS20180945 doi
A549 Cells Animals Antineoplastic Agents--pharmacology Cell Movement--drug effects Epithelial-Mesenchymal Transition--drug effects Extracellular Signal-Regulated MAP Kinases--metabolism Gene Expression Regulation, Neoplastic Humans Liver Neoplasms--genetics Lung Neoplasms--drug therapy Male Melatonin--pharmacology Mice, SCID Neoplasm Invasiveness Nuclear Proteins--genetics Phosphorylation Receptor, Melatonin, MT1--agonists Signal Transduction Twist-Related Protein 1--genetics Type C Phospholipases--metabolism Xenograft Model Antitumor Assays beta Catenin--metabolism p38 Mitogen-Activated Protein Kinases--metabolism